A Phase 4 Study Evaluating Real-World Use of CDPATH, a Crohn's Disease Risk Prediction Tool Protocol Type: Interventional
M
Monika Fischer, MD
Primary Investigator
Overview
The primary objective of the study is to explore the use of a CD risk prediction tool (i.e., CDPATH™) to describe the risk profiles of patients with CD in real-world practice.
Eligibility:
- Participants aged 18 or older
- Crohn's disease (CD) diagnosed within the last five years, without known
complications - Agree to use the CDPATH™ tool
- Additonal criteria must be met based on determination by Investigator and study requirements
Eligibility
You may be eligible for this study if you meet the following criteria:
-
Conditions:
crohns disease,CD
-
Age: Between 18 Years - 100 Years
-
Gender: All
Updated on
26 Apr 2024.
Study ID: 14125
